Economic evaluation(4) C00(4) case control(4) Vaccine(4) A10(4) PHN(4) A(4) Herpeszoster(4) healthcare resource utilization and costs(4) systematic review(4) C(4) administrative claims data(4) Meta-analysis(4) A1(4) herpes zoster(4) immunocompetent population.(4) healthcare resource utilization(3) Spain(3) cost(3) vaccination(3) 50 years(3) pediatric(3) Vaccine-preventable disease(3) VZV(3) varicella virus infection (chickenpox)(3) cost-effectiveness(3) complications(3) Zostavax(3) lenalidomide(1) SARS-CoV-2(1)